Cancer has unfortunately become one of the top causes of death in the world. Due to the complexity of the many forms of cancers, the study and treatment of tumors, called oncology, has become a growing field. However, oncology demands much study and research of physicians pursuing the field. That is why oncologists like Mikhail Blagosklonny are at the forefront of cancer treatment and study.
Blagosklonny started his medical education in Russia. At the prestigious First Pavlov State Medical University of Saint Petersburg, he earned a M.D degree in Internal Medicine. Thereafter, he studied Experimental Medicine and Cardiology which culminated in a Phd. After his studies, Mikhail Blagosklonny applied his education practically for the first time when he began teaching as an associate professor of medicine at New York Medical College in New York. In 2009, following a senior scientist position at Ordway Research Institute, he re-entered the role of educator as a Professor of Oncology at New York-based Roswell Park Cancer Institute.
As a professor and researcher of oncology, Blagosklonny has written and edited over 170 articles of research. He has become such an authority on oncology that he has become the editor of several scholarly publications. He is the founding editor and current editor-in-chief of the publication Cell Cycle. He is also an associate editor of the medical periodicals Cancer Biology and Therapy, PLOS ONE, American Journal of Pathology, Autophagy, Cell Death and Differentiation, Cancer Research and International Journal of Cancer. Source: https://www.linkedin.com/in/mikhail-blagosklonny-91abb531
While currently there is no cure for cancer, the treatment of the various tumors that are known to the medical community are becoming more advanced and effective. One of Mikhail Blagosklonny’s main research targets currently is the development of new anticancer strategies. If one day a cure is found to cancer, Mikhail Blagosklonny may very well be one of the leading contributors to that solution.
Read more about Mikhail Blagosklonny Research Gate